Management of Infantile Spasms During the COVID-19 Pandemic

Zachary M. Grinspan, John R. Mytinger, Fiona M. Baumer, Michael A. Ciliberto, Bruce H. Cohen, Dennis Dlugos, Chellamani Harini, Shaun A. Hussain, Sucheta M. Joshi, Cynthia Keator, Kelly G. Knupp, Patricia E. McGoldrick, Katherine Nickels, Jun Park, Archana Pasupuleti, Anup D. Patel, Asim Shahid, Renée A. Shellhaas, Daniel W. Shrey, Rani K. Singh, Steven M. Wolf, Elissa Yozawitz, Christopher J. Yuskaitis, Jeff L. Waugh, Phillip L. PearlJournal of Child Neurology 2020 · DOI

TL;DR

The COVID-19 pandemic necessitated a rapid adaptation of infantile spasm (IS) management, shifting towards telemedicine and outpatient-first approaches to balance timely diagnosis and treatment with infection risk mitigation. This paper outlines recommendations for diagnosing and treating IS during the pandemic, emphasizing strategies that are either enduring for future healthcare disruptions or limited to the immediate crisis.

What Problem Does This Paper Address?

Infantile spasms (IS), also known as West syndrome, are a severe form of epilepsy that typically affects infants between 2 and 9 months of age. Prompt diagnosis and treatment are crucial for improving outcomes, as delays can lead to significant neurodevelopmental disability. Traditionally, the diagnosis and initial management of IS involve inpatient admissions for video electroencephalography (EEG) and often intravenous or specialized oral medications.

The COVID-19 pandemic presented a significant challenge to this established model. The widespread risk of infection associated with hospital visits, coupled with strained healthcare resources, made traditional inpatient management problematic. This paper addresses the urgent need to adapt IS care protocols to minimize patient and healthcare provider exposure to SARS-CoV-2 while ensuring that infants with IS receive timely and effective treatment. The authors aim to provide guidance that is both practical for the pandemic and potentially beneficial for future healthcare crises.

Methods

The paper presents a set of recommendations developed by the Child Neurology Society and the Pediatric Epilepsy Research Consortium. These recommendations were formulated through a rapid online consensus process during the early stages of the COVID-19 pandemic. The methodology involved:

  • Expert Consensus: A group of pediatric epilepsy experts collaborated to draft immediate recommendations.
  • Literature Review and Synthesis: The recommendations are supported by existing evidence and structured literature reviews.
  • Categorization of Recommendations: Each recommendation is classified as either "enduring" (intended to outlast the pandemic) or "limited" (specific to the pandemic crisis but potentially applicable to future disruptions).
  • Rationale Provision: The manuscript details the reasoning behind each recommendation, explaining how it addresses the challenges posed by the pandemic.

The core of the "method" here is the adaptation of clinical practice based on expert consensus and the principles of public health, rather than a novel experimental design or algorithm.

Datasets

Not discussed in the paper. The paper focuses on clinical guidelines and recommendations rather than empirical research involving specific datasets.

Key Insights and Ideas

  • Telemedicine as a Viable First Step: The paper strongly advocates for using telemedicine or video conferencing for the initial evaluation of suspected infantile spasms. This is a significant shift from the traditional inpatient-focused approach.
  • Parental Video Recordings are Crucial: Empowering parents to capture video recordings of their infant's events is highlighted as a key diagnostic tool, allowing clinicians to assess the characteristic spasms remotely.
  • Prioritizing Oral Therapies: For most etiologies, initiating high-dose oral prednisolone as a first-line treatment in an outpatient setting is recommended over ACTH or vigabatrin, due to its availability and ease of administration, thereby reducing the need for inpatient stays.
  • Outpatient EEG Preference: When EEG confirmation is necessary, the paper emphasizes preferring outpatient EEG over inpatient admission to minimize exposure risks.
  • Enduring vs. Limited Recommendations: The clear distinction between recommendations that should be adopted long-term and those specific to the pandemic context is a valuable framework for adapting healthcare practices.
  • Tuberous Sclerosis Complex Nuances: For infants with tuberous sclerosis complex, vigabatrin remains the preferred treatment if immediately available, but oral prednisolone can be initiated while awaiting it, with a crucial recommendation for echocardiography due to potential cardiac effects of hormonal therapy.

Key Results

The paper does not present quantitative results in the traditional sense, as it is a set of clinical recommendations. However, the "results" are the guidelines themselves, which aim to achieve:

  • Streamlined Diagnosis: Facilitating diagnosis through telemedicine and parental video recordings.
  • Timely Treatment Initiation: Enabling faster initiation of treatment, particularly with oral prednisolone, to avoid delays.
  • Reduced Healthcare Exposure: Minimizing inpatient admissions and the associated risks of COVID-19 transmission.
  • Adaptable Care Models: Providing a framework for managing IS that can be applied during the pandemic and in future healthcare disruptions.

Limitations and Future Work

Limitations:

  • Limited Data for Pandemic-Specific Strategies: The recommendations are based on expert consensus and existing knowledge adapted to the pandemic context, rather than new clinical trials conducted during the pandemic.
  • Potential for Diagnostic Delays: While telemedicine is encouraged, there's an inherent risk that subtle or atypical events might be missed remotely, potentially delaying diagnosis compared to in-person evaluation.
  • Access to Medications: The reliance on oral prednisolone is contingent on its availability and insurance coverage, which can still be a barrier for some.
  • Caregiver Burden: The increased reliance on parental video recording and home administration of medications places a greater burden on caregivers.

Future Work:

  • Long-term Outcomes of Pandemic-Adapted Care: Future research should evaluate the long-term neurodevelopmental outcomes of infants managed with these adapted protocols.
  • Efficacy and Safety of Telemedicine-Based Diagnosis: Studies are needed to rigorously assess the diagnostic accuracy and safety of telemedicine for infantile spasms.
  • Optimization of Outpatient Management: Further investigation into optimizing outpatient EEG and treatment initiation protocols for IS is warranted.
  • Application to Other Pediatric Neurological Emergencies: The strategies developed for IS management during the pandemic could serve as a model for adapting care for other pediatric neurological conditions during public health crises.

Summary updated

Abstract

Circumstances of the COVID-19 pandemic have mandated a change to standard management of infantile spasms. On April 6, 2020, the Child Neurology Society issued an online statement of immediate recommendations to streamline diagnosis and treatment of infantile spasms with utilization of telemedicine, outpatient studies, and selection of first-line oral therapies as initial treatment. The rationale for the recommendations and specific guidance including follow-up assessment are provided in this manuscript. These recommendations are indicated as enduring if intended to outlast the pandemic, and limited if intended only for the pandemic health care crisis but may be applicable to future disruptions of health care delivery.
BibTeX
@article{grinspan2020management,
  author = {Zachary M. Grinspan and John R. Mytinger and Fiona M. Baumer and Michael A. Ciliberto and Bruce H. Cohen and Dennis Dlugos and Chellamani Harini and Shaun A. Hussain and Sucheta M. Joshi and Cynthia Keator and Kelly G. Knupp and Patricia E. McGoldrick and Katherine Nickels and Jun Park and Archana Pasupuleti and Anup D. Patel and Asim Shahid and Renée A. Shellhaas and Daniel W. Shrey and Rani K. Singh and Steven M. Wolf and Elissa Yozawitz and Christopher J. Yuskaitis and Jeff L. Waugh and Phillip L. Pearl},
  title = {{Management of Infantile Spasms During the COVID-19 Pandemic}},
  journal = {Journal of Child Neurology},
  year = {2020},
  doi = {10.1177/0883073820933739},
}
Figure